Tag: Sangamo Therapeutics
November 6, 2019
Sangamo to Present Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data
The company will present data at the 61st Annual Meeting of the American Society of Hematology in Orlando, Florida between...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices. March 18, 2018
5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 15, 2018
Top 10 Stem Cell Companies On The NASDAQ
The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
March 8, 2018
4 Gene Editing Technologies Explained
We look at four types of gene editing currently in clinical trials, as well as the pros and cons of... March 4, 2018